|
1
|
McCarty CA and Taylor HR: Recent
developments in vision research: light damage in cataract. Invest
Ophthalmol Vis Sci. 37:1720–1723. 1996.PubMed/NCBI
|
|
2
|
Nathu Z, Dwivedi DJ, Reddan JR, Sheardown
H, Margetts PJ and West-Mays JA: Temporal changes in MMP mRNA
expression in the lens epithelium during anterior subcapsular
cataract formation. Exp Eye Res. 88:323–330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin EH, Basson MA, Robinson ML, McAvoy JW
and Lovicu FJ: Sprouty is a negative regulator of transforming
growth factor β-induced epithelial-to-mesenchymal transition and
cataract. Mol Med. 18:861–873. 2012.PubMed/NCBI
|
|
4
|
Apple DJ, Solomon KD, Tetz MR, et al:
Posterior capsule opacification. Surv Ophthalmol. 37:73–116. 1992.
View Article : Google Scholar
|
|
5
|
Hodge WG: Posterior capsule opacification
after cataract surgery. Ophthalmology. 105:943–944. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srinivasan Y, Lovicu FJ and Overbeek PA:
Lens-specific expression of transforming growth factor beta1 in
transgenic mice causes anterior subcapsular cataracts. J Clin
Invest. 101:625–634. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Iongh RU, Wederell E, Lovicu FJ and
McAvoy JW: Transforming growth factor-beta-induced
epithelial-mesenchymal transition in the lens: a model for cataract
formation. Cells Tissues Organs. 179:43–55. 2005.PubMed/NCBI
|
|
8
|
Wallentin N, Wickström K and Lundberg C:
Effect of cataract surgery on aqueous TGF-beta and lens epithelial
cell proliferation. Invest Ophthalmol Vis Sci. 39:1410–1418.
1998.PubMed/NCBI
|
|
9
|
Meacock WR, Spalton DJ and Stanford MR:
Role of cytokines in the pathogenesis of posterior capsule
opacification. Br J Ophthalmol. 84:332–336. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Awasthi N, Guo S and Wagner BJ: Posterior
capsular opacification: a problem reduced but not yet eradicated.
Arch Ophthalmol. 127:555–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allen JB, Davidson MG, Nasisse MP,
Fleisher LN and McGahan MC: The lens influences aqueous humor
levels of transforming growth factor-beta 2. Graefes Arch Clin Exp
Ophthalmol. 236:305–311. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eldred JA, Dawes LJ and Wormstone IM: The
lens as a model for fibrotic disease. Philos Trans R Soc Lond B
Biol Sci. 366:1301–1319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akhurst RJ and Hata A: Targeting the TGFβ
signalling pathway in disease. Nat Rev Drug Discov. 11:790–811.
2012.
|
|
14
|
Li J, Tang X and Chen X: Comparative
effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on
proliferation, migration, and extracellular matrix production in a
human lens cell line. Exp Eye Res. 92:173–179. 2011.
|
|
15
|
Dawes LJ, Sleeman MA, Anderson IK, Reddan
JR and Wormstone IM: TGFbeta/Smad4-dependent and -independent
regulation of human lens epithelial cells. Invest Ophthalmol Vis
Sci. 50:5318–5327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung EJ, Chun JN, Jung SA, Cho JW and Lee
JH: TGF-β-stimulated aberrant expression of class III β-tubulin via
the ERK signaling pathway in cultured retinal pigment epithelial
cells. Biochem Biophys Res Commun. 415:367–372. 2011.
|
|
17
|
Chen XF, Zhang HJ, Wang HB, et al:
Transforming growth factor-β1 induces epithelial-to-mesenchymal
transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2
signaling pathways. Mol Biol Rep. 39:3549–3556. 2012.
|
|
18
|
Aomatsu K, Arao T, Sugioka K, et al: TGF-β
induces sustained upregulation of SNAI1 and SNAI2 through Smad and
non-Smad pathways in a human corneal epithelial cell line. Invest
Ophthalmol Vis Sci. 52:2437–2443. 2011.
|
|
19
|
Choi J, Park SY and Joo CK: Transforming
growth factor-beta1 represses E-cadherin production via slug
expression in lens epithelial cells. Invest Ophthalmol Vis Sci.
48:2708–2718. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie L, Law BK, Chytil AM, Brown KA, Aakre
ME and Moses HL: Activation of the Erk pathway is required for
TGF-beta1-induced EMT in vitro. Neoplasia. 6:603–610. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Li Y, Kong D and Sarkar FH: The
role of Notch signaling pathway in epithelial-mesenchymal
transition (EMT) during development and tumor aggressiveness. Curr
Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neuzillet C, Tijeras-Raballand A, de
Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer
therapy. Pharmacol Ther. 141:160–171. 2013. View Article : Google Scholar
|
|
23
|
Tanahashi T, Osada S, Yamada A, et al:
Extracellular signal-regulated kinase and Akt activation play a
critical role in the process of hepatocyte growth factor-induced
epithelial-mesenchymal transition. Int J Oncol. 42:556–564.
2013.
|
|
24
|
Pacheco-Domínguez RL, Palma-Nicolas JP,
López E and López-Colomé AM: The activation of MEK-ERK1/2 by
glutamate receptor-stimulation is involved in the regulation of RPE
proliferation and morphologic transformation. Exp Eye Res.
86:207–219. 2008.PubMed/NCBI
|
|
25
|
Zhang YE: Non-Smad pathways in TGF-beta
signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leask A: Targeting the jagged/notch
pathway: a new treatment for fibrosis? J Cell Commun Signal.
4:197–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
